Tristan Kirby1, Adam E Barry. 1. Organizational Development, Franciscan St. Elizabeth Health, 1501 Hartford Street - Room G137, Lafayette, IN 47904, USA. tristan.kirby@franciscanalliance.org
Abstract
BACKGROUND: The Gateway Drug Theory suggests that licit drugs, such as tobacco and alcohol, serve as a "gateway" toward the use of other, illicit drugs. However, there remains some discrepancy regarding which drug-alcohol, tobacco, or even marijuana-serves as the initial "gateway" drug subsequently leading to the use of illicit drugs such as cocaine and heroin. The purpose of this investigation was to determine which drug (alcohol, tobacco, or marijuana) was the actual "gateway" drug leading to additional substance use among a nationally representative sample of high school seniors. METHODS: This investigation conducted a secondary analysis of the 2008 Monitoring the Future 12th-grade data. Initiation into alcohol, tobacco, and other drug use was analyzed using a Guttman scale. Coefficients of reliability and scalability were calculated to evaluate scale fit. Subsequent cross tabulations and chi-square test for independence were conducted to better understand the relationship between the identified gateway drug and other substances' use. RESULTS: Results from the Guttman scale indicated that alcohol represented the "gateway" drug, leading to the use of tobacco, marijuana, and other illicit substances. Moreover, students who used alcohol exhibited a significantly greater likelihood of using both licit and illicit drugs. CONCLUSION: The findings from this investigation support that alcohol should receive primary attention in school-based substance abuse prevention programming, as the use of other substances could be impacted by delaying or preventing alcohol use. Therefore, it seems prudent for school and public health officials to focus prevention efforts, policies, and monies, on addressing adolescent alcohol use.
BACKGROUND: The Gateway Drug Theory suggests that licit drugs, such as tobacco and alcohol, serve as a "gateway" toward the use of other, illicit drugs. However, there remains some discrepancy regarding which drug-alcohol, tobacco, or even marijuana-serves as the initial "gateway" drug subsequently leading to the use of illicit drugs such as cocaine and heroin. The purpose of this investigation was to determine which drug (alcohol, tobacco, or marijuana) was the actual "gateway" drug leading to additional substance use among a nationally representative sample of high school seniors. METHODS: This investigation conducted a secondary analysis of the 2008 Monitoring the Future 12th-grade data. Initiation into alcohol, tobacco, and other drug use was analyzed using a Guttman scale. Coefficients of reliability and scalability were calculated to evaluate scale fit. Subsequent cross tabulations and chi-square test for independence were conducted to better understand the relationship between the identified gateway drug and other substances' use. RESULTS: Results from the Guttman scale indicated that alcohol represented the "gateway" drug, leading to the use of tobacco, marijuana, and other illicit substances. Moreover, students who used alcohol exhibited a significantly greater likelihood of using both licit and illicit drugs. CONCLUSION: The findings from this investigation support that alcohol should receive primary attention in school-based substance abuse prevention programming, as the use of other substances could be impacted by delaying or preventing alcohol use. Therefore, it seems prudent for school and public health officials to focus prevention efforts, policies, and monies, on addressing adolescent alcohol use.
Authors: Kiffer G Card; Heather L Armstrong; Allison Carter; Zishan Cui; Lu Wang; Julia Zhu; Nathan J Lachowsky; David M Moore; Robert S Hogg; Eric A Roth Journal: Drug Alcohol Depend Date: 2018-05-22 Impact factor: 4.492
Authors: Amy E Ramage; Ai-Ling Lin; Rene L Olvera; Peter T Fox; Douglas E Williamson Journal: Drug Alcohol Depend Date: 2015-01-20 Impact factor: 4.492
Authors: Ida Fredriksson; Sweta Adhikary; Pia Steensland; Leandro F Vendruscolo; Antonello Bonci; Yavin Shaham; Jennifer M Bossert Journal: Neuropsychopharmacology Date: 2016-09-21 Impact factor: 7.853
Authors: Adesola O Olumide; Allysha C Robinson; Paul A Levy; Lawrence Mashimbye; Heena Brahmbhatt; Qiguo Lian; Oladosu Ojengbede; Freya L Sonenstein; Robert W Blum Journal: J Adolesc Health Date: 2014-11-19 Impact factor: 5.012
Authors: Anthony L Berger; Angela M Williams; Molly M McGinnis; Brendan M Walker Journal: Neuropsychopharmacology Date: 2012-11-06 Impact factor: 7.853
Authors: Allison N Kurti; Diana R Keith; Alyssa Noble; Jeff S Priest; Brian Sprague; Stephen T Higgins Journal: Prev Med Date: 2016-09-26 Impact factor: 4.018